Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCI-ImmuneActivator vs Doxorubicin in BCG Refractory Bladder Cancer
NCT00006034Phase 3Completed
- Sponsor
- Intracel
- Start
- Jun 1998
- Countries
- 1
01
Overview
A Phase 3 trial of keyhole limpet hemocyanin in carcinoma in situ of bladder (CIS), sponsored by Intracel. Started Jun 1998; status: completed.
02
Drugs
keyhole limpet hemocyanin
03
Conditions
carcinoma in situ of bladder (CIS)
Beyond the preview
Go deeper on NCT00006034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006034.